153 related articles for article (PubMed ID: 31125077)
1. National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group.
Kawaguchi H; Soejima T; Ishibashi N; Akiba T; Hasegawa M; Isobe K; Ito H; Imai M; Ejima Y; Hata M; Sasai K; Shimoda E; Oguchi M; Akimoto T
J Radiat Res; 2019 Oct; 60(5):579-585. PubMed ID: 31125077
[TBL] [Abstract][Full Text] [Related]
2. National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG).
Ishibashi N; Soejima T; Kawaguchi H; Akiba T; Hasegawa M; Isobe K; Ito H; Imai M; Ejima Y; Hata M; Sasai K; Shimoda E; Maebayashi T; Oguchi M; Akimoto T;
J Radiat Res; 2018 Jul; 59(4):477-483. PubMed ID: 29584887
[TBL] [Abstract][Full Text] [Related]
3. Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years.
Kojima R; Kami M; Kanda Y; Kusumi E; Kishi Y; Tanaka Y; Yoshioka S; Morishima S; Fujisawa S; Mori SI; Kasai M; Hatanaka K; Tajima K; Kasai M; Mitani K; Ichinohe T; Hirai H; Taniguchi S; Sakamaki H; Harada M; Takaue Y
Bone Marrow Transplant; 2005 Oct; 36(8):667-74. PubMed ID: 16113674
[TBL] [Abstract][Full Text] [Related]
4. Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group.
Hoeben BAW; Pazos M; Albert MH; Seravalli E; Bosman ME; Losert C; Boterberg T; Manapov F; Ospovat I; Milla SM; Abakay CD; Engellau J; Kos G; Supiot S; Bierings M; Janssens GO
Radiother Oncol; 2021 Feb; 155():113-119. PubMed ID: 33137397
[TBL] [Abstract][Full Text] [Related]
5. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y
Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric evaluation of ovaries and pelvic bones associated with clinical outcomes in patients receiving total body irradiation with ovarian shielding.
Akahane K; Shirai K; Wakatsuki M; Suzuki M; Hatanaka S; Takahashi Y; Kawahara M; Ogawa K; Takahashi S; Oyama-Manabe N; Ashizawa M; Kimura SI; Kako S; Kanda Y
J Radiat Res; 2021 Sep; 62(5):918-925. PubMed ID: 34350969
[TBL] [Abstract][Full Text] [Related]
8. Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies.
Mineishi S; Kanda Y; Saito T; Nakai K; Makimoto A; Kami M; Tanosaki R; Wakasugi H; Tobinai K; Takaue Y
Br J Haematol; 2003 Apr; 121(2):296-303. PubMed ID: 12694252
[TBL] [Abstract][Full Text] [Related]
9. Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Giebel S; Miszczyk L; Slosarek K; Moukhtari L; Ciceri F; Esteve J; Gorin NC; Labopin M; Nagler A; Schmid C; Mohty M
Cancer; 2014 Sep; 120(17):2760-5. PubMed ID: 24804873
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan.
Kusumi E; Kami M; Kanda Y; Murashige N; Kishi Y; Suzuki R; Takeuchi K; Tanimoto TE; Mori T; Muta K; Tamaki T; Tanaka Y; Ogawa H; Yamane T; Taniguchi S; Takaue Y
Bone Marrow Transplant; 2005 Aug; 36(3):205-13. PubMed ID: 15937505
[TBL] [Abstract][Full Text] [Related]
11. Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study Group.
Shimazaki C; Fujii H; Yoshida T; Chou T; Nishimura M; Asaoku H; Miyawaki S; Ishii A; Ishida T; Taniwaki M; Iida S; Takagi T; Takatsuki K;
Int J Hematol; 2005 May; 81(4):342-8. PubMed ID: 15914367
[TBL] [Abstract][Full Text] [Related]
12. Retrospective multicenter study of allogeneic peripheral blood stem cell transplantation followed by reduced-intensity conditioning or conventional myeloablative regimen.
Kim DH; Sohn SK; Baek JH; Kim JG; Lee JW; Min WS; Kim DW; Choi SJ; Lee JH; Lee KH; Lee MH; Lee JJ; Kim HJ; Kim CC; Lee KB
Acta Haematol; 2005; 113(4):220-7. PubMed ID: 15983427
[TBL] [Abstract][Full Text] [Related]
13. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.
Mikell JL; Waller EK; Switchenko JM; Rangaraju S; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khoury HJ; Khan MK
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):360-9. PubMed ID: 24837891
[TBL] [Abstract][Full Text] [Related]
14. Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.
Imataki O; Kamioka T; Fukuda T; Tanosaki R; Takaue Y
Support Care Cancer; 2010 Dec; 18(12):1565-9. PubMed ID: 20967555
[TBL] [Abstract][Full Text] [Related]
15. Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose?
Adkins DR; DiPersio JF
Curr Opin Hematol; 2008 Nov; 15(6):555-60. PubMed ID: 18832925
[TBL] [Abstract][Full Text] [Related]
16. Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.
Sugita J; Tanaka J; Hashimoto A; Shiratori S; Yasumoto A; Wakasa K; Kikuchi M; Shigematsu A; Miura Y; Tsutsumi Y; Kondo T; Asaka M; Imamura M
Ann Hematol; 2008 Dec; 87(12):1003-8. PubMed ID: 18636260
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation.
Saito T; Kanda Y; Nakai K; Kim SW; Arima F; Kami M; Tanosaki R; Tobinai K; Wakasugi H; Heike Y; Mineishi S; Takaue Y
Bone Marrow Transplant; 2003 Sep; 32(6):601-8. PubMed ID: 12953133
[TBL] [Abstract][Full Text] [Related]
18. A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan.
Imataki O; Kami M; Kim SW; Gotoh M; Komaba S; Kasai M; Hashino S; Naito K; Masuda M; Anan K; Teshima H; Togitani K; Inoue T; Nishimura M; Adachi Y; Fukuhara T; Yamashita T; Uike N; Kobayashi Y; Hamaguchi M; Higuchi M; Kawakami K; Takaue Y
Bone Marrow Transplant; 2004 Jun; 33(12):1173-9. PubMed ID: 15094754
[TBL] [Abstract][Full Text] [Related]
19. [Fungal prophylaxis following reduced-intensity stem cell transplantation (RIST)].
Kami M; Imataki O; Taniguchi S; Kanemaru M; Hayashi T
Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):189-202. PubMed ID: 15550915
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of busulfan-based conditioning regimens for stem cell transplantation against lymphomas in children, adolescents, and young adults in Japan.
Hori D; Kobayashi R; Fujita N; Suzumiya J; Suzuki R; Kato K; Kawata T; Fukuda T; Inoue M; Goto H; Hama A; Iwato K; Okumura H; Eto T; Hashii Y; Atsuta Y; Mitsui T
Pediatr Blood Cancer; 2019 Oct; 66(10):e27918. PubMed ID: 31298481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
